Table 4 Distribution of the immediate adoption by pregnant women of supervised IPTp-SP uptake of the three doses during their facility visit
Number of women who adopt the supervised use of the 3 SP doses | Before the checklist n = 100 | After the checklist n = 100 | p-value |
|---|---|---|---|
Yes | 0 | 59 | < 0.001 |
No | 100 | 41 |
Reasons for not taking SP during pregnant women according to their degree of information | n = 100 | n = 41/100 | |
|---|---|---|---|
I have not eaten yet, and I was told that I could take it at home after a meal to minimize side effects | 75 | 27 | |
The doctor did not explain to me that I must take it immediately here | 20 | 5 | |
There is no water at the facility to take the treatment | 0 | 1 | |
I prefer to take it at home (with more hygiene) | 5 | 7 | |
I must take a blood sample before taking the treatment | 0 | 1 |